Biotech
VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody
The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...
August 10, 2021 | News
Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users
Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to tradi...
August 10, 2021 | News
GenScript to provide the mutant libraries construction to Allozymes
GenScript Biotech Corporation today announced a collaboration with Allozymes, a synthetic biology company transforming ingredient manufacturing by unlockin...
August 04, 2021 | News
Glenmark,SaNOtize to commercialize Nasal Spray for COVID-19 treatment in Asia
Nitric oxide has antimicrobial properties with direct proven effect on SARS-CoV-2 Nitric Oxide Nasal Spray (NONS) has been tested in healthy volunteers ...
August 03, 2021 | News
Neukio Biotherapeutics completed its $40m Angel round financing
Neukio Biotherapeutics, a newly established company, recently announced the completion of its $40m Angel round of financing led by Lilly Asi...
July 30, 2021 | News
Sartorius Stedim Biotech acquires cell culture specialist Xell AG
- Extension of the Sartorius Stedim Biotech cell culture media business with a focus on media for gene therapeutics and vaccines Significant expansion o...
July 29, 2021 | News
GenScript cPass SARS-COV-2 Neutralization Antibody Detection Kit
GenScript Biotech Corporation, a world-leading life sciences research and application service and product provider, announced today that the...
July 28, 2021 | News
Biocon Biologics to Manufacture and Commercialize a Broadly Neutralizing Antibody for India and Select Emerging Markets
Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. , announced today that U.S. based Adagio Therapeutics has gra...
July 26, 2021 | News
LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic
LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...
July 26, 2021 | News
Aurion Biotech Announces IOTA Cell Therapy Trial
-Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced...
July 26, 2021 | News
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership
The agreement outlines a constructive framework where GenFleet will synergize its own R&D systems with Insilico's end-to-end AI-powered drug discovery ...
July 21, 2021 | News
Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio
Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...
July 20, 2021 | News
ArsenalBio Strengthens Leadership Team
ArsenalBio, a privately held programmable cell therapy company, announced that W. Nicholas Haining, BM, BCh, is to be appointed as Chief Scientific Officer...
July 20, 2021 | News
Batavia BioScience produces first clinical product with HIP-VAX platform
Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa...
July 15, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
